RABNIL-20
Description
- Contains Rabeprazole 20 mg – a potent and fast-acting proton pump inhibitor
- Treats GERD, peptic ulcers, acid reflux, and erosive esophagitis
- Inhibits gastric acid secretion at the source
- Promotes mucosal healing in acid-damaged tissues
- Provides 24-hour acid control with once-daily dosing
- Well-tolerated and suitable for long-term use under guidance
- Improves quality of life in acid-related digestive disorders
Composition
RABEPRAZOLE-20 MG
Benefits
RABNIL-20 offers rapid symptom control and long-term management of acid-related disorders. It effectively reduces gastric acidity, promotes healing of ulcers and erosive lesions, and prevents recurrence of heartburn and reflux. Rabeprazole has a fast onset of action and a favorable safety profile, making it ideal for both short-term and chronic use under medical supervision. With once-daily dosing, RABNIL-20 provides consistent acid suppression and improves patients’ quality of life.
Introduction
RABNIL-20 is a proton pump inhibitor (PPI) containing Rabeprazole 20 mg, designed to provide fast and effective relief from acid-related gastrointestinal disorders. Rabeprazole works by suppressing the final step in gastric acid production, thereby reducing excess stomach acid. It is commonly prescribed for conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and erosive esophagitis. RABNIL-20 helps heal and protect the lining of the stomach and esophagus from acid-related damage, offering long-lasting relief from symptoms such as heartburn, indigestion, and acid reflux.
